Cancer-related pain
Conditions
Interventions
Control Group:Standardized pain management nursing care
Trial Group 1 (VR Distraction Mechanism Group):Standardized pain management nursing care + VR distraction mechanism intervention (using PICO 4 to enter exploratory virtual travel scenarios to divert a
Trial Group 2 (Mindfulness-Based Emotional Regulation Mechanism Group):Standardized pain management nursing care + VR mindfulness-based emotional regulation intervention (using PICO 4 to enter virtual
Sponsors
Shanxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Adults (>=18 years) with a confirmed diagnosis of any malignancy who are experiencing cancer-related pain; 2. Patients with a pain score >=4 (moderate to severe pain) who require pain management and are using opioid analgesics during the management process; 3. Patients who are conscious, with good language expression and comprehension ability, and able to cooperate with the study procedures; 4. Patients without severe cardiovascular or cerebrovascular diseases (such as unstable angina, heart failure, uncontrolled hypertension, history of stroke) or other conditions/comorbidities that may affect study safety; 5. Patients without contraindications to the use of VR devices (such as severe vertigo, history of epilepsy, severe visual or auditory impairment); 6. Patients who voluntarily participate in the study, provide informed consent, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who are currently participating in other studies; 2. Patients who have recently received other research interventions that may affect this study; 3. Patients who are expected to be unable to complete the study in the short term, such as those with rapidly progressing disease or a short anticipated survival period, making it impossible to complete the study and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cortisol level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain relief rate;Reduction rate in analgesic drug usage;Incidence of opioid-induced hyperalgesia (OIH);Sleep quality;Quality of life; | — |
Countries
China
Contacts
Public ContactSheng Ruishan
Shanxi Medical University
Outcome results
None listed